Neuropsychiatric Safety With Liraglutide 3.0 Mg for Weight Management: Results From Randomized Controlled Phase 2 and 3a Trials

Diabetes, Obesity and Metabolism - United Kingdom
doi 10.1111/dom.12963
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Real‐World Clinical Effectiveness of Liraglutide 3.0 Mg for Weight Management in Canada

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2019English

Effect of Liraglutide on Blood Pressure: A Meta-Analysis of Liraglutide Randomized Controlled Trials

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2019English

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

Archives of Internal Medicine
2009English

Liraglutide and Cardiovascular Outcomes in Adults With Overweight or Obesity: A Post Hoc Analysis From SCALE Randomized Controlled Trials

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

How Should a Clinician Interpret Results of Randomized Controlled Trials?: Interpretation of Randomized Controlled Trials

Acta medica Lituanica
2010English

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

Headache
Neurology
2019English

Randomized Controlled Trials

Phlebology
MedicineCardiovascular MedicineCardiology
2011English

Randomized Controlled Trials

JAMA - Journal of the American Medical Association
Medicine
2005English

MDMA-assisted Psychotherapy for Treatment of PTSD: Study Design and Rationale for Phase 3 Trials Based on Pooled Analysis of Six Phase 2 Randomized Controlled Trials

Psychopharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy